Your privacy is important to us. Cookies are very small text files that are stored on your computer when you visit a website. We use cookies and other tracking technologies for a variety of purposes and to enhance your online experience on our website. You can change your preferences and decline certain types of cookies to be stored on your computer while browsing our website. You can also remove any cookies already stored on your computer, but keep in mind that deleting cookies may prevent you from using parts of our website. You can check our privacy policy page for more information.
-
eventOn November 9, PhRMA underwrote The Atlantic’s annual People v. Cancer event. PhRMA’s Chief Operating Officer Lori Reilly sat down with Catherine Owen, SVP and GM of US Commercialization at Bristol Myers Squibb, for a conversation about the future of oncology R&D.
During their fireside chat, “The Role of Small Molecules in the Fight Against Cancer,” Lori and Catherine discussed the advancements Bristol Myers Squibb and the broader biopharmaceutical industry have made in cancer treatments, and the unique role of small molecule medicines in oncology. Looking forward, Catherine and Lori outlined how the Inflation Reduction Act’s “pill penalty” could limit the future of small molecule medicine innovation.
November 9, 2023, at 10:30 AM ET
This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.